WHO ICTRP trial
To study how Ripasudil can help for graft survival after corneal transplant
CTRI/2024/06/069429 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/06/069429 |
|---|---|
| Public title | To study how Ripasudil can help for graft survival after corneal transplant |
| Scientific title | A prospective comparative study to evaluate the effect of different Rho kinase inhibitors as a co adjuvant for endothelial cell survival in post Penetrating Keratoplasty patients |
| Primary sponsor | Malvika Gokhale |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: H179- Unspecified corneal scar and opacity |
| Interventions | Intervention1: Ripasudil eye drops: Topical Ripasudil drops- 3 drops/day, from first post operative day, for a duration of 6 months Control Intervention1: Predmet, vigamox, cyclomune eye drops: Topical Predmet drops with a tapering dose… |
| Registration date | Jun 24, 2024 |
| Target size | 40 |
| Secondary IDs | New ID |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: